Natus Medical (BABY) Tops Q3 EPS by 5c; Guides Above the Street

October 19, 2016 6:04 AM EDT
Get Alerts BABY Hot Sheet
Trade BABY Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Natus Medical (NASDAQ: BABY) reported Q3 EPS of $0.39, $0.05 better than the analyst estimate of $0.34. Revenue for the quarter came in at $90.9 million versus the consensus estimate of $89.94 million.

GUIDANCE:

Natus Medical sees Q4 2016 EPS of $0.52-$0.55, versus the consensus of $0.48. Natus Medical sees Q4 2016 revenue of $107-109 million, versus the consensus of $104.6 million.

Natus Medical sees FY2016 EPS of $1.63-$1.66, versus the consensus of $1.55. Natus Medical sees FY2016 revenue of $381.2-383.2 million, versus the consensus of $377.83 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment